The impact of PDD for Urological cancer

The impact of PDD for Urological cancer - PDD for urological cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009093

Enrollment

100

Registered

2012-10-15

Start date

2012-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genitourinary cancer

Interventions

5 ALA p.o.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients of bladder cancer who will be performed TURBT.

Exclusion criteria

Exclusion criteria: The patients with hyper sensitivity for 5ALA.

Design outcomes

Primary

Measure	Time frame
sensitivity, specificity, recurrece free survival,positive predictive value	—

Countries

Japan

Contacts

Public ContactTakaoka Eiichiro

Tsukuba University hospital Department of Urology

tach-tech-voice@mvb.biglobe.ne.jp0298533223

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026